Ferramenta de IA para dilemas éticos corporativos

Lar

Lista de Prompts de IA

Filosofia/Religião

Auxílio à decisão ética

${:__('collect %s',Auxílio à decisão ética)}$

Filosofia/Religião

Use a IA para analisar dilemas éticos comerciais, equilibrar os interesses das partes interessadas e gerar recomendações de decisão moralmente sólidas.

Conteúdo do prompt

Copiar

Act as a corporate ethics consultant to analyze a current business moral dilemma. This situation involves a conflict between maximizing profits and fulfilling social responsibilities, specifically where a product may cause slight but long-term environmental damage, while stopping production would lead to layoffs. Consider the interests of shareholders, employees, the community, and the environment based on utilitarian and deontological ethical frameworks. Evaluate the moral weight of different action plans and output a brief report containing risk assessment, interest balancing analysis, and a final recommended decision, ensuring the advice is actionable and aligns with long-term corporate values.

Copiar

Atue como consultor de ética corporativa para analisar um dilema moral comercial atual. Esta situação envolve um conflito entre a maximização dos lucros e o cumprimento das responsabilidades sociais, especificamente em um cenário onde um produto pode causar danos ambientais leves, mas de longo prazo, enquanto a interrupção da produção levaria a demissões. Considere os interesses dos acionistas, funcionários, comunidade e meio ambiente conforme as estruturas éticas utilitaristas e deontológicas. Avalie o peso moral de diferentes planos de ação e emita um relatório breve contendo avaliação de riscos, análise de equilíbrio de interesses e uma decisão final recomendada, garantindo que o conselho seja executável e esteja alinhado com os valores de longo prazo da empresa.

Copiar

Compartilhar Clique para copiar o link

Comentários (0)

0/300

Enviar

Recomendação

Apoio à decisão ética

Act as a senior corporate ethics consultant to conduct a deep moral assessment of the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has mild but irreversible neurological side effects with long-term use, yet discontinuing the drug would cause severe deterioration for many chronic patients. Please analyze the trade-offs between disclosing information, adjusting pricing, developing alternatives, and assuming social responsibility by integrating utilitarian impacts on overall well-being with deontological respect for patient autonomy and the principle of non-maleficence. Provide a comprehensive action plan that balances commercial sustainability with moral integrity, focusing on how to protect patient rights while ensuring the company's long-term viability.

Auxílio à decisão ética

Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that a rare side effect of its marketed drug may cause serious health risks with long-term use, but recalling it would lead to bankruptcy and affect thousands of employees' livelihoods, while concealing it violates patient safety principles. Please evaluate the moral weight of three options—public disclosure, partial recall, or complete concealment—by combining the utilitarian view of the greatest happiness for the greatest number with the deontological view of respecting individual rights and the duty of honesty, and provide a specific action recommendation that balances social responsibility and corporate survival, ensuring the decision-making process is transparent and compliant with business ethics norms.

Auxílio à decisão ética

Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but under-disclosed side effects with long-term use. Continuing sales increases profit but may harm some patients, while recalling it causes massive losses and job cuts. Please evaluate the moral weight of both paths by combining the impact on overall well-being from utilitarianism with the emphasis on the duty of honest disclosure from deontology, and provide a balanced recommendation that considers legal compliance, corporate survival, and social responsibility, avoiding absolute moral judgments and instead offering a decision framework based on stakeholder analysis.

Auxílio à decisão ética

Act as a corporate ethics consultant to conduct a deep moral analysis of the following specific business scenario: A pharmaceutical company discovers that its high-profit, already marketed drug has minor but long-term side effects. Recalling it would cause massive financial losses and affect shareholder interests, but not recalling it might harm some patients' health. Please evaluate the ethical weights of both recall and non-recall choices by combining two philosophical frameworks: utilitarianism (greatest happiness for the greatest number) and deontology (moral nature of the act itself, such as honesty and non-maleficence). Avoid simple binary judgments; instead, derive the best action path that is morally defensible and aligns with long-term Corporate Social Responsibility (CSR) by weighing the interests of various stakeholders (patients, shareholders, employees, society), and explain the reasoning.

Auxílio à decisão ética

Act as a corporate ethics consultant to evaluate the following business scenario: A pharmaceutical company discovers its best-selling drug has minor but negligible side effects with long-term use, yet concealing this information would cause a stock crash and impact employee benefits. Analyze the moral risks of concealment using both utilitarian consequentialism and Kantian deontology, weigh shareholder interests against patient safety, and provide a decision recommendation that balances compliance with corporate social responsibility, ensuring logical consistency and adherence to business ethical standards.

Auxílio à decisão ética

Act as a senior corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company developing a life-saving drug faces a dilemma regarding whether to partially release clinical trial data to accelerate approval, potentially sacrificing some subjects' privacy for greater public health benefits. Combine the utilitarian principle of maximizing happiness with the deontological respect for individual rights to evaluate the ethical risks of this decision. Provide a balanced solution that considers legal compliance, social responsibility, and long-term brand reputation, avoiding simple binary judgments, and focus on how to balance procedural justice with outcome justice.